In vitro and in silico evaluation of new thiazole compounds as monoamine oxidase inhibitors

Bioorg Chem. 2019 Apr:85:97-108. doi: 10.1016/j.bioorg.2018.12.019. Epub 2018 Dec 13.

Abstract

New twenty compounds bearing thiazole ring (3a-3t) were designed and synthesized as monoamine oxidase (MAO) inhibitors. The fluorometric enzyme inhibition assay was used to determine the biological effects of synthesized compounds. Most of them showed remarkable inhibitory activity against both MAO-A and MAO-B. By comparing their IC50 values, it can be seen that active derivatives displayed generally selectivity on MAO-B enzyme. Compounds 3j and 3t, which bear dihydroxy moiety at the 3rd and 4th position of phenyl ring, were the most active derivatives in the series against both isoenzymes. Compounds 3j and 3t showed significant inhibition profile on MAO-A with the IC50 values of 0.134 ± 0.004 µM and 0.123 ± 0.005 µM, respectively, while they performed selectivity against MAO-B with the IC50 values of 0.027 ± 0.001 µM and 0.025 ± 0.001 µM, respectively. Also, docking studies about these compounds were carried out to evaluate their binding modes on the active regions of MAO-A and MAO-B.

Keywords: Enzyme inhibitor activity; MAO inhibitors; Molecular docking; Thiazole derivatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Catalytic Domain
  • Dogs
  • Humans
  • Madin Darby Canine Kidney Cells
  • Mice
  • Molecular Docking Simulation
  • Monoamine Oxidase / chemistry
  • Monoamine Oxidase / metabolism
  • Monoamine Oxidase Inhibitors / chemical synthesis
  • Monoamine Oxidase Inhibitors / metabolism
  • Monoamine Oxidase Inhibitors / pharmacokinetics*
  • NIH 3T3 Cells
  • Protein Binding
  • Thiazoles / chemical synthesis
  • Thiazoles / metabolism
  • Thiazoles / pharmacokinetics*

Substances

  • Monoamine Oxidase Inhibitors
  • Thiazoles
  • Monoamine Oxidase
  • monoamine oxidase A, human